Atlas Trials

Rovi Pharmaceuticals Laboratories

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Rovi Pharmaceuticals Laboratories

RecordFirmDate
A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (NCT07340658)Rovi Pharmaceuticals Laboratories2026-08-01
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer (NCT07401381)Rovi Pharmaceuticals Laboratories2026-06-08
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (NCT06276361)Rovi Pharmaceuticals Laboratories2023-09-26
Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women (NCT06315205)Rovi Pharmaceuticals Laboratories2023-07-26
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (NCT05480046)Rovi Pharmaceuticals Laboratories2022-10-18
Comparative Bioavailability of Risperidone. (NCT05179525)Rovi Pharmaceuticals Laboratories2021-03-09
Comparative Bioavailability of Risperidone (NCT03527186)Rovi Pharmaceuticals Laboratories2018-07-09
Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1) (NCT03401320)Rovi Pharmaceuticals Laboratories2017-11-06

Track Rovi Pharmaceuticals Laboratories automatically

Every clearance here is in the API, with alerts when new ones post.